The University of Oxford researcher is testing a revolutionary injection to prevent the appearance of lung cancer, the most common and deadly form of the disease
While the UK is not short of life science start-up companies there is a disconnect when it comes to scaling up, with many choosing to relocate to other markets with perceived better opportunities, writes Sarah Brereton, Director at Limewash Media.